ArticleVaccines2024

COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region.

Manuela Runge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.